If you have taken ranitidine (also known by its brand name Zantac) and been diagnosed with cancer, you may be eligible for financial compensation through a ranitidine cancer lawsuit. Ranitidine lawsuits have already been filed by people who allege the drug’s makers designed a defective product and failed to warn about the risks.
We are available to file a Zantac lawsuit on your behalf if you have been harmed by either the brand name or generic version of the heartburn medicine.
Does ranitidine cause cancer? Analyses by Valisure, an online pharmacy, and the US Food and Drug Administration (FDA), found increased levels of NDMA, a known carcinogen, in ranitidine products. As a result of those findings, the FDA ultimately requested a Zantac recall of all ranitidine products.
Class Action Claim Center has an extensive history of successfully fighting for the rights of people harmed by drug companies. Attorney Paul Dahlberg has obtained more than $60 million in compensation for our clients, including those harmed by drugs and medical devices.
If you took ranitidine (Zantac) contact Class Action Claim Center today to discuss how we can help you protect your rights. Our initial consultations are free and no-obligation.
FDA Ranitidine Recall
On September 13, 2019, Valisure filed a petition asking that the FDA recall ranitidine after the pharmacy found high levels of NDMA in the medication. The pharmacy noted that its research found the NDMA was caused by “inherent instability in the ranitidine molecule.
When it sent its petition, Valisure CEO David Light noted, “There’s no acceptable cancer risk for a drug like this.”
On April 1, 2020, the FDA announced it was asking makers of all prescription and over-the-counter ranitidine (Zantac) drugs to remove their products from the market.
The agency made its announcement after it learned that NDMA in some ranitidine products could increase in certain situations. An increase in NDMA is linked to increased cancer risk.
“Low levels of NDMA are commonly ingested in the diet, for example, NDMA is present in food and water,” FDA said in its announcement. “These low levels would not be expected to lead to an increased risk of cancer. However, sustained higher levels of exposure may increase the risk of cancer in humans.”
An examination of ranitidine—a heartburn medication—showed that NDMA levels increased under normal storage conditions, and increased significantly when stored at higher temperatures. The temperatures studied were similar to those the drug could be stored during distribution or consumer use.
Tests also showed that the levels of NDMA increased more dramatically in products that had been on the shelf longer. In other words, the longer the product is stored for before it is used, the greater the risk of exposure.
Zantac (Ranitidine) Cancer
We are investigating ranitidine lawsuits on behalf of people who took the medication and later developed any of the following cancers:
- Liver cancer
- Intestinal cancer
- Stomach cancer
- Pancreatic cancer
- Kidney cancer
- Colon cancer
- Bladder cancer
- Esophageal cancer
Protecting Consumers from Dangerous Drugs
Ranitidine is a widely used drug in a class known as histamine-2 blockers. It is sold in both prescription and over-the-counter formulations to treat or prevent heartburn. As a prescription medication, it can also treat and prevent ulcers in the stomach and intestines.
It is unacceptable that so many people are at risk of cancer because they were not adequately warned about its risks.
Class Action Claim Center helps consumers fight back against drug companies. Our clients have faced serious health consequences due to pharmaceutical company greed. If you’ve been harmed by Zantac, you could face expensive medical bills, lost wages due to time off work, and pain and suffering as the result of health problems that were not your fault.
We fight to help people like you to recover financial compensation when drug companies cause harm. Our clients trust us to deliver results that maximize their claims and protect their families.
If you used prescription, over-the-counter, or generic Zantac (ranitidine) and have been diagnosed with cancer, contact Class Action Claim Center today for a no-obligation review of your claim.
Zantac Cancer Lawsuit FAQ
Why are people filing ranitidine cancer lawsuits?
Ranitidine lawsuits are being investigated on behalf of people who took Zantac or ranitidine and were later diagnosed with cancer. The Zantac lawsuits allege that the drugmakers either knew or should have known about the risk of NDMA exposure and cancer but did not properly warn patients about those risks.
What grounds are there for filing a Zantac lawsuit?
People filing Zantac cancer lawsuits allege they took the heartburn medication thinking it was safe and would not have taken it had they known there was an unacceptable risk of cancer. They argue that the manufacturers marketed the drug as safe but either knew it was not safe or failed to conduct adequate testing to uncover the risk of cancer.
Is there evidence that Zantac causes cancer?
There is evidence that Zantac contains NDMA, which is listed as a probable human carcinogen. This means that based on animal studies, NDMA can probably cause cancer in humans.
A 2016 study of ranitidine found that users who took 150mg ranitidine doses excreted more than 47000 ng of NDMA in their urine, 400 times more than than they excreted before ranitidine exposure
Furthermore, a 2004 study of men with peptic ulcer disease found that those taking ranitidine or cimetidine (Tagamet) had an increased risk of bladder cancer.
What is NDMA?
NDMA (known scientifically as N-Nitrosodimethylamine) is a chemical classified as a probable human carcinogen based on laboratory test results. That means it could potentially cause cancer. According to scientists, NDMA modifies human DNA. In animal experiments conducted in laboratories, NDMA has been linked to an increase in the risk of cancer.
The Environmental Protection Agency (EPA) classifies NDMA as a probable human carcinogen, while the International Agency for Research on Cancer (IARC) classifies it as probably carcinogenic to humans.
In a publication regarding NDMA, the IARC states that NDMA “should be regarded for practical purposes as if it were carcinogenic to humans.”
What does the FDA say about ranitidine?
On April 1, 2020, the FDA requested that all companies that manufacture ranitidine recall their products. As a result, more than a dozen companies have recalled Zantac and other ranitidine medications. This includes both prescription and over-the-counter ranitidine.
Although low levels of NDMA may not be carcinogenic, “sustained higher levels of exposure may increase the risk of cancer in humans,” the FDA writes. NDMA levels appear to increase the older a ranitidine product is.
How do I know if I’ve experienced NDMA side effects?
- Liver problems
- Kidney problems
- Abdominal cramps
Who makes ranitidine medications?
The following manufacturers make ranitidine:
- American Health Packaging
- Amneal Pharmaceuticals
- Aurobindo Pharma USA
- Apotex Corp
- Appco Pharma
- Denton Pharma (dba Northwind Pharmaceuticals)
- Reddy’s Laboratories
- Glenmark Pharmaceuticals
- Golden State Medical Supply
- Lannett Company
- Novitium Pharma
- Perrigo Company
- Precision Dose
Are there Zantac class-action lawsuits being filed?
Yes. A ranitidine class action lawsuit has been filed on behalf of patients who took Zantac believing the medication was safe. Lawsuits have been filed against GlaxoSmithKline and Sanofi, alleging both drugmakers failed to warn patients that they could be at increased risk of exposure to NDMA and thus an increased risk of cancer.
The lawsuits argue that no reasonable person would have purchased or taken Zantac if they had known that the medication increased the risk of excessive NDMA exposure. Plaintiffs say they relied on the manufacturers’ labels that represented the drugs as safe.
Can I join a ranitidine class action lawsuit?
If you purchased and took ranitidine (Zantac) believing it was safe, you may be eligible to join a class action claim.
Are there Zantac injury lawsuits currently filed?
Yes, personal injury lawsuits have been filed against the makers of Zantac and ranitidine, alleging patients were not properly warned about the link between the medication and cancer.
What is the difference between a Zantac Class Action Lawsuit and a Zantac Cancer lawsuit?
A Zantac class action lawsuit is filed on behalf of people who bought Zantac believing it was safe and want to recover the money they spent purchasing the medication. These lawsuits compensate consumers who purchased the medication and hold the drug company accountable for profiting from not warning consumers about the risks.
Anyone who purchased ranitidine and did not develop cancer can file or join a Zantac class-action lawsuit.
A Zantac cancer lawsuit is filed on behalf of patients who were diagnosed with cancer after taking Zantac (ranitidine). These would either be a Zantac personal injury lawsuit or a Zantac wrongful death lawsuit (when filed by people whose family members died from their cancer). Individual lawsuits allow victims to obtain maximum compensation based on their specific injuries and circumstances.
How can Class Action Claim Center help me with a ranitidine cancer lawsuit?
A ranitidine lawsuit can help you and people like you in two important ways:
1. It can ensure you are financially compensated for any expenses, lost wages, or other financial losses you experienced as a result of your Zantac use.
2. It can provide financial compensation for any pain and suffering caused as a result of your Zantac use.
Attorney Paul Dahlberg of Class Action Claim Center has a reputation for successfully fighting against drug companies. He was lead counsel for Paxil litigation in Minnesota and has fought for consumers against the makers of IVC filters, Belviq and Nuplazid. Our firm has obtained hundreds of millions of dollars in compensation for our clients, people like you who were harmed by someone else’s actions.
We fight ceaselessly against drug companies to hold them accountable for putting profits ahead of people and we advocate for patients’ rights. Patients like you should never be put at risk of a serious side effect like cancer by taking a drug that was marketed as safe.
Contact a ranitidine injury lawyer today to protect your rights
Does ranitidine cause cancer? Based on the evidence available from numerous studies, we believe the NDMA in ranitidine can cause cancer in patients who take the medication.
You may be eligible to file a Zantac lawsuit. If you or someone you love took ranitidine or Zantac and were diagnosed with cancer, contact Class Action Claim Center today to discuss a potential ranitidine cancer lawsuit. Fill out a claim form or call us at 507-424-3000.